Filing Details

Accession Number:
0000899243-17-026604
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-11-16 16:45:29
Reporting Period:
2017-11-15
Accepted Time:
2017-11-16 16:45:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1466301 Clovis Oncology Inc. CLVS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1268304 C Gillian Ivers-Read C/O Clovis Oncology, Inc.
5500 Flatiron Parkway, Suite 100
Boulder CO 80301
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-11-15 3,000 $63.70 185,583 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $63.62 to $64.13. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 6, 2017.